Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|August 14, 2009
Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptidesAugen A Pioszak, Naomi R Parker, Thomas J Gardella, et al.
JBMR Plus|June 20, 2022
Functional Properties of Two Distinct PTH1R Mutants Associated With Either Skeletal Defects or PseudohypoparathyroidismIgnacio Portales-Castillo, Thomas Dean, Ashok Khatri, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2018
Receptor selectivity from minimal backbone modification of a polypeptide agonistShi Liu, Ross W Cheloha, Tomoyuki Watanabe, et al.
Cell Chemical Biology|June 23, 2021
Activity-based, bioorthogonal imaging of phospholipase D reveals spatiotemporal dynamics of GPCR-Gq signalingDongjun Liang, Ross W Cheloha, Tomoyuki Watanabe, et al.
Nature Biotechnology|June 16, 2014
Backbone modification of a polypeptide drug alters duration of action in vivoRoss W Cheloha, Akira Maeda, Thomas Dean, et al.
ACS Chemical Biology|August 18, 2016
Backbone Modification of a Parathyroid Hormone Receptor-1 Antagonist/Inverse AgonistRoss W Cheloha, Tomoyuki Watanabe, Thomas Dean, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 19, 2016
Prolonged Pharmacokinetic and Pharmacodynamic Actions of a Pegylated Parathyroid Hormone (1-34) Peptide FragmentJun Guo, Ashok Khatri, Akira Maeda, et al.
Trends in Endocrinology and Metabolism: TEM|November 9, 2019
PTH/PTHrP Receptor Signaling, Allostery, and StructuresIeva Sutkeviciute, Lisa J Clark, Alex D White, et al.
Molecular Endocrinology (Baltimore, Md.)|January 14, 2015
Actions of the small molecule ligands SW106 and AH-3960 on the type-1 parathyroid hormone receptorPercy H Carter, Thomas Dean, Brijesh Bhayana, et al.
The Journal of Biological Chemistry|November 1, 2018
Parathyroid hormone(1-34) and its analogs differentially modulate osteoblastic Rankl expression via PKA/SIK2/SIK3 and PP1/PP2A-CRTC3 signalingFlorante R Ricarte, Carole Le Henaff, Victoria G Kolupaeva, et al.
Pageof 8